Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy

Matrix metalloproteinases (MMPs) are secreted proteinases that have physiologic roles in degradation and remodeling of extracellular matrix (ECM) in almost all tissues. However, their excessive production in disease conditions leads to many pathological features including tissue breakdown, inflammat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogura, Yuji, Tajrishi, Marjan M., Sato, Shuichi, Hindi, Sajedah M., Kumar, Ashok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207008/
https://www.ncbi.nlm.nih.gov/pubmed/25364719
http://dx.doi.org/10.3389/fcell.2014.00011
_version_ 1782340907860754432
author Ogura, Yuji
Tajrishi, Marjan M.
Sato, Shuichi
Hindi, Sajedah M.
Kumar, Ashok
author_facet Ogura, Yuji
Tajrishi, Marjan M.
Sato, Shuichi
Hindi, Sajedah M.
Kumar, Ashok
author_sort Ogura, Yuji
collection PubMed
description Matrix metalloproteinases (MMPs) are secreted proteinases that have physiologic roles in degradation and remodeling of extracellular matrix (ECM) in almost all tissues. However, their excessive production in disease conditions leads to many pathological features including tissue breakdown, inflammation, cell death, and fibrosis. Duchenne Muscular dystrophy (DMD) is a devastating genetic muscle disorder caused by partial or complete loss of cytoskeletal protein dystrophin. Progressive muscle wasting in DMD is accompanied by myofiber necrosis followed by cycles of regeneration and degeneration and inflammation that eventually result in replacement of myofiber by connective and adipose tissues. Emerging evidence suggests that gene expression and the activity of various MMPs are aberrantly regulated in muscle biopsies from DMD patients and in skeletal muscle of animal models of DMD. Moreover, a few studies employing genetic mouse models have revealed that different MMPs play distinct roles in disease progression in DMD. Modulation of the activity of MMPs improves myofiber regeneration and enhances the efficacy of transplantation and engraftment of muscle progenitor cells in dystrophic muscle in mouse models of DMD. Furthermore, recent reports also suggest that some MMPs especially MMP-9 can serve as a biomarker for diagnosis and prognosis of DMD. In this article, we provide a succinct overview of the regulation of various MMPs and their therapeutic importance in DMD.
format Online
Article
Text
id pubmed-4207008
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-42070082014-10-31 Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy Ogura, Yuji Tajrishi, Marjan M. Sato, Shuichi Hindi, Sajedah M. Kumar, Ashok Front Cell Dev Biol Cell and Developmental Biology Matrix metalloproteinases (MMPs) are secreted proteinases that have physiologic roles in degradation and remodeling of extracellular matrix (ECM) in almost all tissues. However, their excessive production in disease conditions leads to many pathological features including tissue breakdown, inflammation, cell death, and fibrosis. Duchenne Muscular dystrophy (DMD) is a devastating genetic muscle disorder caused by partial or complete loss of cytoskeletal protein dystrophin. Progressive muscle wasting in DMD is accompanied by myofiber necrosis followed by cycles of regeneration and degeneration and inflammation that eventually result in replacement of myofiber by connective and adipose tissues. Emerging evidence suggests that gene expression and the activity of various MMPs are aberrantly regulated in muscle biopsies from DMD patients and in skeletal muscle of animal models of DMD. Moreover, a few studies employing genetic mouse models have revealed that different MMPs play distinct roles in disease progression in DMD. Modulation of the activity of MMPs improves myofiber regeneration and enhances the efficacy of transplantation and engraftment of muscle progenitor cells in dystrophic muscle in mouse models of DMD. Furthermore, recent reports also suggest that some MMPs especially MMP-9 can serve as a biomarker for diagnosis and prognosis of DMD. In this article, we provide a succinct overview of the regulation of various MMPs and their therapeutic importance in DMD. Frontiers Media S.A. 2014-04-01 /pmc/articles/PMC4207008/ /pubmed/25364719 http://dx.doi.org/10.3389/fcell.2014.00011 Text en Copyright © 2014 Ogura, Tajrishi, Sato, Hindi and Kumar. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Ogura, Yuji
Tajrishi, Marjan M.
Sato, Shuichi
Hindi, Sajedah M.
Kumar, Ashok
Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy
title Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy
title_full Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy
title_fullStr Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy
title_full_unstemmed Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy
title_short Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy
title_sort therapeutic potential of matrix metalloproteinases in duchenne muscular dystrophy
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207008/
https://www.ncbi.nlm.nih.gov/pubmed/25364719
http://dx.doi.org/10.3389/fcell.2014.00011
work_keys_str_mv AT ogurayuji therapeuticpotentialofmatrixmetalloproteinasesinduchennemusculardystrophy
AT tajrishimarjanm therapeuticpotentialofmatrixmetalloproteinasesinduchennemusculardystrophy
AT satoshuichi therapeuticpotentialofmatrixmetalloproteinasesinduchennemusculardystrophy
AT hindisajedahm therapeuticpotentialofmatrixmetalloproteinasesinduchennemusculardystrophy
AT kumarashok therapeuticpotentialofmatrixmetalloproteinasesinduchennemusculardystrophy